Skip to main content
Fig. 3 | Cancer Nanotechnology

Fig. 3

From: Utilizing two-dimensional monolayer and three-dimensional spheroids to enhance radiotherapeutic potential by combining gold nanoparticles and docetaxel

Fig. 3

Docetaxel characterization in HeLa. a, b Proliferation assays for a (a) two-dimensional monolayer and a (b) three-dimensional spheroid, for the cervical cancer cell line HeLa, treated with docetaxel. c, d Cell cycle analysis of a (c) monolayer and (d) spheroids of HeLa cells treated with the GR50 dose of docetaxel, calculated per modality

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us